Small Molecules for Cancer or Autoimmunity Icon

Cambridge Healthtech Institute’s 4th Annual

Small Molecule Immuno-Modulators

Combatting Cancer, Autoimmunity and Inflammation with the Immune System

APRIL 11 - 12, 2023


This conference covers small molecule compounds that either activate or dampen the immune system to fight diseases such as cancer, autoimmunine conditions, and inflammation-related disorders. Join fellow discovery chemists to share and rejoice in the renaissance of small molecule approaches that are enabling progress in an area of drug discovery that was most recently the domain of biologics. Evidence of the role of the immune system in many diseases continues to grow, revealing many culprit molecule that are intracellular thus only accessible only to small molecule modulators, as opposed to biologics. Join medicinal chemistry colleagues to hear and discuss examples of small molecule immuno-oncology drug candidates and other early-stage compounds that modulate the immune system and have therapeutic potential with the promise of oral bioavailability.

For more details on the conference, please contact:

Anjani Shah, PhD

Senior Conference Director and Lead Content Director for Drug Discovery Chemistry

Cambridge Healthtech Institute

Phone: (+1) 781-247-6252



For sponsorship information, please contact:

Kristin Skahan

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5431